Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning.
Source check: Source checked. Not independent scientific confirmation.
Finding: Primary Methods/Results identify CEBPA, CXCL2, JUN and FOXO1 as shared CAD/NAFLD candidate biomarkers using three ML selectors, then evaluate them in separate GEO datasets.
Technology: GEO GSE113079/GSE89632 training; LASSO, SVM-RFE and RF intersection; GSE42148/GSE159676 validation and ROC analysis.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- GEO GSE113079/GSE89632 training; LASSO, SVM-RFE and RF intersection; GSE42148/GSE159676 validation and ROC analysis.
- Test and result
- GEO GSE113079/GSE89632 training; LASSO, SVM-RFE and RF intersection; GSE42148/GSE159676 validation and ROC analysis.
- Limitation / still unknown
- Independent transcriptomic validation supports exploratory diagnostic candidates, but no prospective clinical or experimental validation establishes clinical utility or causal mechanism.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41598-025-87923-7
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.